Search for: "MOLECULAR SYSTEMS, INC." Results 101 - 120 of 182
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Apr 2013, 11:50 am
The Association for Molecular Pathology (and other plaintiffs) sued Myriad, seeking invalidation of the contested claims. [read post]
17 Mar 2015, 10:02 pm by Roy Costa, RS, MS (MBA)
., a registered professional sanitarian and founder/owner of Environ Health Associates Inc. [read post]
17 Jan 2018, 3:18 am by Nate Nead
”[2] The Office of Disease Prevention and Health Promotion projected that by 2030, more than 60% of the “baby boomer” generation will be managing at least one chronic illness or condition.[3] As the world’ population ages, there will be greater pressure on the healthcare system for inexpensive and accurate diagnostics. [read post]
17 Mar 2020, 1:32 pm by Noble McIntyre
Level 1® Fast Flow Fluid Warming System, NORMOFLO® Fluid Warmer, and Level 1® Normothermic I.V. [read post]
11 May 2011, 7:46 am by Stefanie Levine
Patent No. 5,804,375 entitled REACTION MIXTURES FOR DETECTION OF TARGET NUCLEIC ACIDS and owned by Roche Molecular Systems. [read post]
11 May 2011, 7:46 am by Stefanie Levine
Patent No. 5,804,375 entitled REACTION MIXTURES FOR DETECTION OF TARGET NUCLEIC ACIDS and owned by Roche Molecular Systems. [read post]
8 Oct 2009, 6:05 am
Teva Pharmaceuticals USA, Inc (Patent Docs) (Patent Baristas) (GenericsWeb)   General Biotech legislative agenda: healthcare, energy, patents and capital (IP Watch) India: Applying for patents does pay: Wockhardt wins kudos from the Indian government (SPICY IP) US: CAFC ruling in Board of Trustees of the Leland Stanford Junior University et al v Roche Molecular Systems et al - How to lose a patent? [read post]
7 Jun 2011, 6:29 am by Nabiha Syed
Molecular Systems, Inc, the Court upheld the “first to invent” rule, holding that the Bayh-Dole Act does not automatically vest title to federally funded inventions in the universities in which the research is being conducted. [read post]
11 Mar 2009, 5:19 pm
  The application must also show that the two products are highly similar in molecular structure and share the same mechanism(s) of action, if known. [read post]
22 Mar 2011, 4:21 pm by Marie Louise
: Board of Trustees of Leland Stanford Junior University v Roche Molecular Systems Inc (IPKat) US: That was unexpectedly…  well… expected: BPAI affirms Examiner’s obviousness rejection in Ex Parte Akio Ochiai concerning a health food product containing curcumin, scymnol and isoflavones (BT-IP Notes) US: VirginiaTech VERSUS series – Drug evaluation DVDs available (FDA Law Blog) Products Diovan HCT (Valsartan, Hydrochlorothiazide) –… [read post]